Summary.-Following a single injection of MNU into " intact " mice, a high incidence of leukaemia (900o) is obtained, with a 500% induction time of 200 days. Immunological studies indicate that the 0 antigen is expressed on the leukaemic cells.
IN AN IMPORTANT paper recently, Haran-Ghera and Peled (1973) found that dimethylbenz(a)anthracene (DMBA) will produce specifically B lymphocyte leukaemia in several mouse strains tested, whereas radiation and virus produce T lymphocyte leukaemias. Subsequently, it was shown (Haran-Ghera, 1973 ) that transplant of bone marrow, 80 days after DMBA treatment, into syngeneic mice resulted in a 100% incidence of leukaemia in the recipients within 20 days. Here we describe another chemically (methylnitrosourea) induced leukaemia which shows some essential differences from the DMBA induced B lymphocyte leukaemia.
MATERIALS AND METHODS
Mice.-Female BDF1 (C57B1 x DBA/2 FI) mice, 8-10 weeks old were used. Thymectomy (Kaplan, 1950) or splenectomy (Schofield and Cole, 1968) was performed when the animals were 4-6 weeks old. Experimental animals were kept 3 to a cage and supplied with food and water ad libitum.
Irradiation.-X-rays were produced by a Siemens Stabilipan x-ray machine operating at 300 kVp and 12 mA, with a half value layer of 2 mm Cu. Dose rate was 30 rad/min.
Chemicals.-The nitrosamide, methylnitrosourea (MNU) was chosen for the chemical induction of leukaemia. It is a highly effective carcinogen and can induce a wide variety of tumours (Druckrey et al., 1961 (Druckrey et al., , 1964 including lymphomata in mice after a single injection (Joshi and Frei, 1970a, b) . MNU was synthesized in these laboratories by Dr A. W. Craig and stored as a crystalline solid at -20°C. For experimental use MNU was dissolved in ice-cold physiological saline and the solution sterilized by passage through a millipore filter, pore-size 0*22 1um. This solution was then injected into one of the lateral tail veins of unanaesthetized mice. MNU solution was always made up freshly at a concentration of 2 mg/ml and used within 5 min of its dissolving. When the change in optical density at 230 nm was followed, in a cell maintained at 4°C by passing iced water through thermospacers, it was found that less than 10% of the compound had decomposed within the first 10 min. It has previously been shown (Druckrey et al., 1967 ) that MNU has a short halflife in vivo and, in contrast with the nitrosamines, needs no enzyme activation.
Pathology of leukaemias.-Animals suspected of having leukaemia were killed and various tissues were taken for histological examination, including peripheral lymph nodes (superficial cervical, axillary, brachial, mesenteric and inguinal), thymus, spleen and liver, and occasionally bone marrow. Other organs were taken only if grossly involved.
In the majority of instances, the malignancy of the cells was estimated by re-transplantation studies; 5 x 105-107 spleen, bone marrow or thymus cells were injected intravenously into three 8-10 week old BDFL mice. The latent period and gross pathology of any resulting leukaemias were recorded.
T lymphocyte deficient animals.-These were obtained by thymectomy at 4-6 weeks of age, followed 2 weeks later by potentially lethal irradiation (850 rad x-rays) and immediate reconstitution with a graft of 106 syngeneic bone marrow cells. In such animals T lymphocytes are numerically few, but normal numbers of B lymphocytes are found (Miller and Mitchell, 1969 The possibility that the leukaemogenic activity is a secondary manifestation of a primary effect on host tissues other than those producing haemopoietic cells, was tested in the following way: " Intact " mice were treated with 50 mg/kg MNU, followed 24 h later by 500 rad x-rays (with this combination of treatments the additive cytotoxic effects are such that no animals survive without marrow grafting). Immediately after x-irradiation the animals received a graft of 2 x 106 untreated bone marrow cells (containing approximately 600 CFUs) and a subcutaneous implant (axillary region) of thymus from syngeneic mice of the same age. Out of a group of 25 mice, no animals developed leukaemia (Table ID) .
Pathology and transplantability of MN U induced leukaemia
Histological findings are shown in Table II The primary MNU induced leukaemias were tested also for the presence of 0 antigen in a cytotoxicity assay based on release of chromium 51 (Wigzell, 1965) using AKR anti-OC3H serum prepared by the method of Reif and Allen (1964) and guinea-pig serum absorbed with agarose as a source of complement. All tests were performed in quadruplicate and the average number of counts released per tube with 0 antiserum, normal mouse serum and with the detergent triton, was calculated (Raff and Wortis, 1970) Although the spleen is generally involved in the presentation of the leukaemia, splenectomy had little effect upon the incidence or induction time of MNIU induced leukaemias, similar to methyleholanthrene induced leukaemia in DBA mice (Law and Miller, 1950) and x-ray induced lymphoid leukaemia in RF mice (Upton et al., 1958) . This may mean that splenectomy does not permanently affect the number of " target cells " available for leukaemic transformation.
Leukaemias arising in thymectomized MNU treated mice seem distinct from those appearing in " intact " or splenectomized mice in that they have a prolonged induction time and are characterized by a high number of animals presenting with mesenteric lymph node involvement. The reported effect of thymectomy on the incidence of lymphoid leukaemia is variable, in some cases causing a pronounced reduction in the incidence of leukaemia (Kaplan, Brown and Paull, 1953; Law and Miller, 1950; Peled and Haran-Ghera, 1971) , in others having little effect either on the induction times or the incidence of leukaemia (Haran-Ghera and Peled, 1973) . The variable effect of thymectomy upon the incidence of leukaemia produced in mice by different treatments may depend upon " target " specificity of the leukaemogen. Adult thymectomy prevents further processing of pre-T cells to T cells and leads to an impairment of cell mediated immunity in old age. If the initial target cell for leukaemogenesis were the pre-T (or an earlier precursor cell) which had subsequently to be processed by the thymus before leukaemic change became apparent, then thymectomy would be expected to have an inhibitory effect on leukaemia development. However, it would have little influence on the induction of a leukaemia involving only B lymphocytes. This was indeed found to be the case in DMBA induced leukaemia in SJL/J mice where leukaemia involved B lymphocytes and its incidence was essentially similar in intact, thymectomized or T lymphocyte deficient mice (Haran-Ghera and Peled, 1973) . In our experiments, whilst thymectomy alone reduced the incidence somewhat and prolonged the latent period, it did not prevent leukaemias from developing.
However, in T lymphocyte deficient (thymectomized, irradiated, bone marrow reconstituted) mice, with a " normal " complement of B cells, leukaemias did not develop following MIN{J treatment. Furthermore, our failure to induce significant levels of leukaemia in potentially lethally irradiated mice (where the thymus architecture is available for the processing of pre-T cells and as a site for leukaemia development) or in potentially lethally irradiated thymectomized mice (not able to process pre-T cells) by reconstituting them with MNUJ treated bone marrow (either 1 day or 70 days post MNU treatment) suggests that concomitant with the absence of MNU treated T lymphocytes, the target cells have also been lost. This would imply that the haemopoietic stem cells andpre-T cells injectedare not the " MNU leukaemia " inducing cells, and that the likely target cell for MNU leukaemia is the T lymphocyte (which would not be expected to be present in significant numbers in the injected bone marrow). The initial studies with cell surface markers, showing a uniform absence of B lymphocyte surface markers in leukaemic tissue and the general susceptibility of the leukaemic cells to cytotoxic 0 antiserum, are in keeping with such a hypothesis. The low anti-O cytotoxic indices in the spleens of leukaemic mice showing no thymus involvement (Group D, Table III ) and the concomitant absence of surface Ig could at this stage be taken to implicate also a pre-T or even a non-T type of cell, or simply " masking " of the expression of antigens on the leukaemic cells. There are, however, no indications that this would belong to the B cell differentiation pathway, since even in thymectomized mice the leukaemias arising after MN(U treatment do not carry Ig surface markers, but do express 0 antigen.
Whether the inability to induce B lymphocyte leukaemias after MNU (compared with DMBA) is due to mouse strain differences or to differences in the mechanism of action of various chemical leukaemogens will have to be elucidated. The technical assistance of Miss N. Higgins is gratefully acknowledged.
